Tungsten E2's Ease of Use, Long Battery Life and
Non-volatile Memory Provides Secure, Accurate Capture of Clinical
Trial Data in the Field
MILPITAS, Calif., April 13 palmOne, Inc.today announced that
invivodata inc., an industry leader in electronic patient reported
outcome (PRO) solutions for clinical research, has plans to deploy
between 5,000 and 7,000 Tungsten E2 handhelds from palmOne for
use in worldwide clinical trials during the next 90 days. As the
demand for invivodata's unique electronic diary system, DiaryPRO
continues to grow, the number of deployed devices could easily
be four times that amount by the end of 2005.
[NOTE: See today's related article, "palmOne
Introduces the Tungsten E2 Handheld."]
By combining behavioral science and clinical expertise with palmOne's
proven handheld technology, invivodata's electronic diary system
increases patient compliance with reporting requirements to more
than 90 percent, (See: Handhelds
enhance protocol compliance up to 94%) up from less
than 20 percent with conventional paper-based diaries. This dramatic
increase in compliance delivers higher-integrity PRO data that
trial sponsors can rely upon as they evaluate the effectiveness
of new treatments. In fact, invivodata's electronic diary has
successfully delivered key data for multiple new drug approvals
granted by the Food and Drug Administration (FDA).
"By deploying our scientific expertise on palmOne's newest
handheld product, we will continue to deliver unique solutions
that streamline the clinical drug development process and put
patients back at the center of research where they belong,"
said Doug Engfer, president and chief executive officer of invivodata.
"We look forward to standardizing on the Tungsten E2 as our
device of choice and leveraging its flexibility and ease of use
in clinical trials throughout the world."
The Tungsten E2 builds on the popularity of the Tungsten E handheld,
which has sold nearly 2 million units worldwide. The Tungsten
E2's non-volatile memory and Bluetooth technology are key enablers
for clinical trial use. While non-volatile memory keeps trial
data secure, Bluetooth technology enables integration with physiological
devices, such as peak flow meters, a standard tool used in respiratory
"With the ever-increasing importance being placed on high-quality
patient- reported data, we answered our customers' demand by delivering
a handheld computer with non-volatile, flash memory to keep all
information on the product safe, even if there's no time to recharge,"
said Tara Griffin, vice president, Americas Sales, for palmOne.
"It's rewarding to see how invivodata and its pharmaceutical,
biotech and medical device company clients will benefit from all
of the Tungsten E2's new features."